RxDoctor Payments Data

Manoj Menon, MD

Hematology & Oncology · Seattle, WANPI 1407037278

Payments from drug & device makers

$297,050in general payments, 2019–2025

Across 4 payments — averaging $74,262 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cepheid$297K

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Cepheid4$297,050

How this compares

$297,050 in reported general payments places this provider in the 70th percentile of 349 hematology & oncology providers in Washington.

See all hematology & oncology providers in Washington

Medicare billing

Part B allowed, 2024
$9,064
Medicare patients
44
Services billed
107

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BosulifBosutinib12$242,018
CalquenceAcalabrutinib Maleate11$159,521
Abiraterone Acetate31$48,066
Hydroxyurea22$659
Acyclovir15$160
Prednisone32$120
Dexamethasone14$22

Paid to pharmacies, not to this prescriber.

Other hematology & oncology in Seattle

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →